Call for Proposals

CMIEDF offers financial support to innovators, developers, and academic institutions in Canada, specifically in the field of radiopharmaceutical and medical isotope technologies. This funding is designed to expedite the progress of early-stage programs, thereby creating a continuous pipeline for development and eventual commercialization.

CMIEDF has $5 million to dedicate to advancing medical isotope technologies within Canada. Individual project support will range from $50-500k. CMIEDF will provide a reimbursement up to 50% of eligible project costs when at least 50% of the project is funded by non-federal government sources. Additionally, each project must actively involve at least one small to medium enterprise (SME).

For radiopharmaceutical programs, we are seeking programs spanning from the pre-clinical proof of concept phase to early clinical trials and progressing into the pre-commercialization stage.

UPDATE: OUR FIRST CALL FOR PROPOSALS IS NOW CLOSED.

Dear CMIE Community,

We’re thrilled to announce the conclusion of our inaugural Call for Proposals! Thanks to all the fantastic applicants and those who expressed interest in the CMIE Development Fund.

Next Steps:

The CMIE selection committee will review the applications and those selected to move forward to the second stage can expect to be notified by February 15th. Stay tuned for updates!

Save the Date:

Mark your calendars! The next Call for Proposals is set to open Fall 2024.

Stay Connected:

Don’t miss out on the latest updates! Subscribe to our mailing list for real-time information on the next funding round and upcoming CMIE events.

If there are any questions regarding the CMIEDF application process, please contact us at funding@cmie.ca

FREQUENTLY ASKED QUESTIONS

This application is open to Canadian small to medium enterprises (SMEs), academic institutions, not-for-profit organizations, multi-national enterprises (MNEs), and research institutes. Each project must actively involve at least one SME.

This funding cycle will support radiopharmaceutical and medical isotope technology research programs. We are seeking programs with high impact collaborations that foster business and technology development with enhanced emphasis on commercialization. Eligible programs can be at a Technology Readiness Level (TRL) of 1-9.

For radiopharmaceutical programs, we are seeking programs spanning from the pre-clinical proof of concept phase to early clinical trials and progressing into the pre-commercialization stage.

Program funding can be requested between $50,000 and $500,000. CMIEDF will provide a reimbursement up to 50% of eligible project costs when at least 50% of the project is funded by non-federal government sources.

The current Call for Proposals will open December 15, 2023. The first round of applications will close on January 31, 2024, at 11:59pm Pacific Standard Time (PST). 

Projects can begin no earlier than the awarded date and end no later than September 2025. Projects should be less than 12 months in length. 

All applications must be submitted through the CMIEDF funding portal, which will become available December 15, 2023.

Join our community, it's free!

Receive the latest news and updates on funding calls and networking events.

Name(Required)